David Roman
Stock Analyst at Goldman Sachs
(2.17)
# 2,766
Out of 4,749 analysts
23
Total ratings
46.15%
Success rate
-0.59%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Neutral | $384 → $427 | $391.29 | +9.13% | 2 | Jan 30, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $81 → $90 | $72.45 | +24.22% | 3 | Dec 5, 2024 | |
| HQY HealthEquity | Initiates: Neutral | $108 | $110.42 | -2.19% | 1 | Nov 15, 2024 | |
| TDOC Teladoc Health | Initiates: Buy | $14 | $10.16 | +37.80% | 1 | Nov 15, 2024 | |
| DOCS Doximity | Initiates: Neutral | $58 | $59.10 | -1.86% | 1 | Nov 15, 2024 | |
| LIVN LivaNova | Initiates: Buy | $65 | $49.95 | +30.13% | 1 | Oct 4, 2024 | |
| IRTC iRhythm Technologies | Initiates: Neutral | $78 | $108.85 | -28.34% | 1 | Oct 4, 2024 | |
| TNDM Tandem Diabetes Care | Initiates: Neutral | $46 | $37.06 | +24.12% | 1 | Oct 4, 2024 | |
| SOLV Solventum | Maintains: Sell | $48 → $54 | $74.06 | -27.09% | 3 | Aug 12, 2024 | |
| BAX Baxter International | Maintains: Neutral | $36 → $40 | $32.56 | +22.85% | 2 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $102.36 | -12.08% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $571.88 | -12.57% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $121 | $127.93 | -5.42% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $247.60 | +10.66% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $129 | $109.48 | +17.83% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $83 | $90.82 | -8.61% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $87 | $88.30 | -1.47% | 1 | May 30, 2024 |
Stryker
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $391.29
Upside: +9.13%
Edwards Lifesciences
Dec 5, 2024
Maintains: Buy
Price Target: $81 → $90
Current: $72.45
Upside: +24.22%
HealthEquity
Nov 15, 2024
Initiates: Neutral
Price Target: $108
Current: $110.42
Upside: -2.19%
Teladoc Health
Nov 15, 2024
Initiates: Buy
Price Target: $14
Current: $10.16
Upside: +37.80%
Doximity
Nov 15, 2024
Initiates: Neutral
Price Target: $58
Current: $59.10
Upside: -1.86%
LivaNova
Oct 4, 2024
Initiates: Buy
Price Target: $65
Current: $49.95
Upside: +30.13%
iRhythm Technologies
Oct 4, 2024
Initiates: Neutral
Price Target: $78
Current: $108.85
Upside: -28.34%
Tandem Diabetes Care
Oct 4, 2024
Initiates: Neutral
Price Target: $46
Current: $37.06
Upside: +24.12%
Solventum
Aug 12, 2024
Maintains: Sell
Price Target: $48 → $54
Current: $74.06
Upside: -27.09%
Baxter International
Aug 8, 2024
Maintains: Neutral
Price Target: $36 → $40
Current: $32.56
Upside: +22.85%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $102.36
Upside: -12.08%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $571.88
Upside: -12.57%
May 30, 2024
Initiates: Buy
Price Target: $121
Current: $127.93
Upside: -5.42%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $247.60
Upside: +10.66%
May 30, 2024
Initiates: Neutral
Price Target: $129
Current: $109.48
Upside: +17.83%
May 30, 2024
Initiates: Sell
Price Target: $83
Current: $90.82
Upside: -8.61%
May 30, 2024
Initiates: Neutral
Price Target: $87
Current: $88.30
Upside: -1.47%